N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

Details for Australian Patent Application No. 2006238888 (hide)

Owner Goldstein, G.

Inventors Not Given

Agent Cullen & Co

Pub. Number AU-A-2006238888

PCT Pub. Number WO2006/116353

Priority 60/673,561 21.04.05 US; 60/705,967 05.08.05 US

Filing date 21 April 2006

Wipo publication date 2 November 2006

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

C07C 321/00 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116353 Priority application(s): WO2006/116353

3 April 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to include inventor Goldstein, Glenn A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006238892-Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs

2006238887-Object-delivery shuttle